Skyrizi

Active substance

Holder

Status

closed

Indication

treatment of patients with active Crohn's Disease who have no other suitable

treatment option and are not eligible to participate in a clinical study for their serious or life-threatening condition

Public documents

Approbation

Information for the patient

Informed consent

Last update

21/02/2023